As the Vice President of Research and inaugural Director of CAMH’s Campbell Family Mental Health Research Institute, Dr. Pollock has led an expansion of CAMH’s research enterprise. He leads a team of more than 120 scientists and 600 research staff committed to making discoveries to improve the quality of life for people served by CAMH and beyond, through brain science, clinical research, and policy and population health research. Dr. Pollock is also the inaugural Peter and Shelagh Godsoe Chair in Late-Life Mental Health at the University of Toronto and CAMH, and Professor of Psychiatry and Pharmacology at the University of Toronto.
Dr. Pollock earned his MD from the Faculty of Medicine of the University of Toronto, and his PhD in pharmacology from the University of Pittsburgh, School of Medicine. He is a practicing geriatric psychiatrist, listed in Best Doctors in Canada and Best Doctors in America, and served as the President of the American Association for Geriatric Psychiatry. Dr. Pollock's research includes clinical studies examining neurochemical selectivity, pharmacometrics and effects of conventional or newly derived agents for the treatment of depression and the behavioral disturbances of dementia. He has published over 300 peer-reviewed publications and is listed by ISI as among the 1% most cited authors in geriatric psychiatry.
His research has been recognized by the Distinguished Investigator Award of the American Association for Geriatric Psychiatry, the Jack Weinberg Memorial Award for excellence in Geriatric Psychiatry from the American Psychiatric Association, the Award for Research in Geriatric Psychiatry by the American College of Psychiatrists, and the 2014 William B. Abrams Award in Geriatric Clinical Pharmacology from the American Society for Clinical Pharmacology and Therapeutics.